Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

CUSIP: 51654W101

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
11,280,432
Total 13F shares
2,284,349
Share change
+33,179
Total reported value
$9,928,721
Price per share
$4.35
Number of holders
31
Value change
+$166,361
Number of buys
12
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BIOS Capital Management, LP
13F
Company
9.5%
1,075,952
$3,400,008 30 Jun 2025
13F
Aaron G.l. Fletcher
3/4/5
10%+ Owner
9.5%
1,075,952
$3,344,781 -$500,290 13 Jun 2025
Leslie W. Kreis
3/4/5
10%+ Owner
9.5%
1,075,952
$3,344,781 -$500,290 13 Jun 2025
VANGUARD GROUP INC
13F
Company
3.2%
363,720
$1,149,355 30 Jun 2025
13F
CM Management, LLC
13F
Company
1.8%
200,000
$632,000 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.81%
91,891
$290,438 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.8%
90,600
$286,296 30 Jun 2025
13F
NewEdge Advisors, LLC
13F
Company
0.5%
56,507
$178,561 30 Jun 2025
13F
Voss Capital, LP
13F
Company
0.44%
50,000
$158,000 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
0.37%
42,275
$133,589 30 Jun 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.36%
40,940
$129,370 30 Jun 2025
13F
Westside Investment Management, Inc.
13F
Company
0.32%
35,900
$113,444 30 Jun 2025
13F
HORIZON KINETICS ASSET MANAGEMENT LLC
13F
Company
0.24%
27,582
$87,159 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.23%
26,482
$83,683 30 Jun 2025
13F
DAVENPORT & Co LLC
13F
Company
0.23%
25,814
$81,572 30 Jun 2025
13F
UBS Group AG
13F
Company
0.22%
24,653
$77,903 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.21%
23,652
$74,740 30 Jun 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.16%
18,161
$57,000 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.14%
15,589
$49,261 30 Jun 2025
13F
XTX Topco Ltd
13F
Company
0.11%
12,624
$39,892 30 Jun 2025
13F
Sanctuary Advisors, LLC
13F
Company
0.09%
10,000
$31,600 30 Jun 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.04%
4,986
$15,756 30 Jun 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.03%
2,972
$9,392 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.02%
2,730
$8,627 30 Jun 2025
13F
SBI Securities Co., Ltd.
13F
Company
0.02%
2,154
$6,807 30 Jun 2025
13F
CURIO WEALTH, LLC
13F
Company
0.02%
2,000
$6,320 30 Jun 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
1,157
$3,656 30 Jun 2025
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0.01%
800
$2,528 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.01%
601
$1,899 30 Jun 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
500
$1,580 30 Jun 2025
13F
Parkside Financial Bank & Trust
13F
Company
0%
260
$822 30 Jun 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
215
$679 30 Jun 2025
13F
Newbridge Financial Services Group, Inc.
13F
Company
0%
200
$632 30 Jun 2025
13F
Allworth Financial LP
13F
Company
0%
100
$316 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
77
$243 30 Jun 2025
13F
FMR LLC
13F
Company
0%
74
$234 30 Jun 2025
13F
Key FInancial Inc
13F
Company
0%
2
$6 30 Jun 2025
13F
Franklyn G. Prendergast
3/4/5
Director
class O/S missing
3,200
04 Nov 2021

Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q3 2025

As of 30 Sep 2025, Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,284,349 shares. The largest 10 holders included BIOS Capital Management, LP, VANGUARD GROUP INC, CM Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Voss Capital, LP, NewEdge Advisors, LLC, BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
34
Q3 2025 holders
31
Holder diff
-3
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.